ID

17597

Description

Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG); ODM derived from: https://clinicaltrials.gov/show/NCT00093886

Link

https://clinicaltrials.gov/show/NCT00093886

Keywords

  1. 9/25/16 9/25/16 -
Uploaded on

September 25, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT00093886

Eligibility Hypertension NCT00093886

Criteria
Description

Criteria

provide written informed consent before initiation of any study related procedures.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
be at least 18 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
be scheduled for coronary artery bypass grafting (cabg), off pump coronary artery bypass (opcab), minimally invasive direct coronary artery bypass (midcab) surgery, and/or valve replacement/repair surgery
Description

Coronary Artery Bypass Surgery | Coronary Artery Bypass, Off-Pump | Minimally invasive direct coronary artery bypass | Heart valve replacement | Repair of heart valve

Data type

boolean

Alias
UMLS CUI [1]
C0010055
UMLS CUI [2]
C1449706
UMLS CUI [3]
C1690495
UMLS CUI [4]
C0190173
UMLS CUI [5]
C0190112
prerandomization exclusion criteria:
Description

Exclusion Criteria Randomization Before

Data type

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0034656
UMLS CUI [1,3]
C0332152
women of child-bearing potential (unless they have a negative pregnancy test)
Description

Childbearing Potential Pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
recent cerebrovascular accident (within 3 months before randomization)
Description

Cerebrovascular accident Recent

Data type

boolean

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0332185
known intolerance to calcium channel blockers
Description

intolerance to Calcium Channel Blockers

Data type

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0006684
known or suspected hypersensitivity to nitroglycerin
Description

Hypersensitivity Nitroglycerin

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0017887
allergy to soybean oil or egg lecithin (components of the lipid vehicle)
Description

Hypersensitivity Soybean Oil | Hypersensitivity egg lecithin

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0037732
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0772274
pre-existing permanent ventricular pacing
Description

Ventricular pacing Permanent Pre-existing

Data type

boolean

Alias
UMLS CUI [1,1]
C0429115
UMLS CUI [1,2]
C0205355
UMLS CUI [1,3]
C2347662
any other disease or condition, which, in the judgment of the investigator would place a patient at undue risk by being enrolled in the trial
Description

Disease Study Subject Participation Status At risk | condition Study Subject Participation Status At risk

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1444641
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C1444641
participation in another therapeutic drug or therapeutic device trial within 30 days of starting study
Description

Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C2346570
postrandomization inclusion criteria:
Description

Inclusion criteria Randomization Post

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0034656
UMLS CUI [1,3]
C0687676
determined to be hypertensive perioperatively as determined by the investigator
Description

Hypertensive perioperative

Data type

boolean

Alias
UMLS CUI [1,1]
C0857121
UMLS CUI [1,2]
C1518988

Similar models

Eligibility Hypertension NCT00093886

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Informed Consent
Item
provide written informed consent before initiation of any study related procedures.
boolean
C0021430 (UMLS CUI [1])
Age
Item
be at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Coronary Artery Bypass Surgery | Coronary Artery Bypass, Off-Pump | Minimally invasive direct coronary artery bypass | Heart valve replacement | Repair of heart valve
Item
be scheduled for coronary artery bypass grafting (cabg), off pump coronary artery bypass (opcab), minimally invasive direct coronary artery bypass (midcab) surgery, and/or valve replacement/repair surgery
boolean
C0010055 (UMLS CUI [1])
C1449706 (UMLS CUI [2])
C1690495 (UMLS CUI [3])
C0190173 (UMLS CUI [4])
C0190112 (UMLS CUI [5])
Exclusion Criteria Randomization Before
Item
prerandomization exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
Childbearing Potential Pregnancy test negative
Item
women of child-bearing potential (unless they have a negative pregnancy test)
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Cerebrovascular accident Recent
Item
recent cerebrovascular accident (within 3 months before randomization)
boolean
C0038454 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
intolerance to Calcium Channel Blockers
Item
known intolerance to calcium channel blockers
boolean
C1744706 (UMLS CUI [1,1])
C0006684 (UMLS CUI [1,2])
Hypersensitivity Nitroglycerin
Item
known or suspected hypersensitivity to nitroglycerin
boolean
C0020517 (UMLS CUI [1,1])
C0017887 (UMLS CUI [1,2])
Hypersensitivity Soybean Oil | Hypersensitivity egg lecithin
Item
allergy to soybean oil or egg lecithin (components of the lipid vehicle)
boolean
C0020517 (UMLS CUI [1,1])
C0037732 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0772274 (UMLS CUI [2,2])
Ventricular pacing Permanent Pre-existing
Item
pre-existing permanent ventricular pacing
boolean
C0429115 (UMLS CUI [1,1])
C0205355 (UMLS CUI [1,2])
C2347662 (UMLS CUI [1,3])
Disease Study Subject Participation Status At risk | condition Study Subject Participation Status At risk
Item
any other disease or condition, which, in the judgment of the investigator would place a patient at undue risk by being enrolled in the trial
boolean
C0012634 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
participation in another therapeutic drug or therapeutic device trial within 30 days of starting study
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Inclusion criteria Randomization Post
Item
postrandomization inclusion criteria:
boolean
C1512693 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
Hypertensive perioperative
Item
determined to be hypertensive perioperatively as determined by the investigator
boolean
C0857121 (UMLS CUI [1,1])
C1518988 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial